It does sound like Hims is going down this path, with lots of language during Q2 on educating consumers around Hims capabilities across multiple dimensions
"That is very different from a drug actually causing a new cancer." Patients using GLP-1 therapy typically have more medical appointments, specialized care and diagnostic imaging
Weight loss depends on many different factors, including diet, exercise, and sleep habits
Sitagliptin, the main active ingredient in Januvia and Janumet, restrains the DPP-4 protein, which plays a role in glucose metabolism
This dual mechanismreduced hunger signals plus physical fullnesscreates a powerful synergy that changes not just how much you eat, but how you think about eating
Image Credit: Nefedova Tanya / Shutterstock A recent study published in The Lancet evaluated the safety and efficacy of oral semaglutide in people with early Alzheimers disease (AD)